Knight Therapeutics Inc. (GUD.TO)
CAD 5.21
(-0.19%)
CAD 5.21
(-0.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 91.83 Million CAD | -0.71% |
| 2022 | 92.48 Million CAD | 27.75% |
| 2021 | 72.39 Million CAD | 28.12% |
| 2020 | 56.5 Million CAD | -20.27% |
| 2019 | 70.87 Million CAD | 6138.56% |
| 2018 | 1.13 Million CAD | -7.19% |
| 2017 | 1.22 Million CAD | 54.94% |
| 2016 | 790 Thousand CAD | -45.89% |
| 2015 | 1.46 Million CAD | 142.61% |
| 2014 | 601.78 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 95.4 Million CAD | 3.88% |
| 2024 Q2 | 103.64 Million CAD | 8.64% |
| 2023 Q4 | 91.83 Million CAD | -18.33% |
| 2023 Q2 | 98.68 Million CAD | -0.31% |
| 2023 Q1 | 98.98 Million CAD | 7.03% |
| 2023 Q3 | 112.44 Million CAD | 13.95% |
| 2023 FY | 91.83 Million CAD | -0.71% |
| 2022 Q3 | 84.94 Million CAD | 11.18% |
| 2022 Q2 | 76.4 Million CAD | -0.33% |
| 2022 FY | 92.48 Million CAD | 27.75% |
| 2022 Q1 | 76.65 Million CAD | 5.88% |
| 2022 Q4 | 92.48 Million CAD | 8.88% |
| 2021 Q1 | 55.04 Million CAD | -2.59% |
| 2021 Q4 | 72.39 Million CAD | -3.36% |
| 2021 Q3 | 74.91 Million CAD | 34.29% |
| 2021 Q2 | 55.78 Million CAD | 1.34% |
| 2021 FY | 72.39 Million CAD | 28.12% |
| 2020 Q3 | 61.78 Million CAD | -13.99% |
| 2020 Q4 | 56.5 Million CAD | -8.54% |
| 2020 FY | 56.5 Million CAD | -20.27% |
| 2020 Q2 | 71.83 Million CAD | -0.4% |
| 2020 Q1 | 72.12 Million CAD | 1.77% |
| 2019 FY | 70.87 Million CAD | 6138.56% |
| 2019 Q4 | 70.87 Million CAD | 14914.83% |
| 2019 Q3 | 472 Thousand CAD | -43.41% |
| 2019 Q2 | 834 Thousand CAD | -0.24% |
| 2019 Q1 | 836 Thousand CAD | -26.41% |
| 2018 Q4 | 1.13 Million CAD | -7.87% |
| 2018 Q2 | 966 Thousand CAD | -2.82% |
| 2018 Q1 | 994 Thousand CAD | -18.79% |
| 2018 FY | 1.13 Million CAD | -7.19% |
| 2018 Q3 | 1.23 Million CAD | 27.64% |
| 2017 Q2 | 839 Thousand CAD | 21.77% |
| 2017 Q4 | 1.22 Million CAD | 87.44% |
| 2017 FY | 1.22 Million CAD | 54.94% |
| 2017 Q1 | 689 Thousand CAD | -12.78% |
| 2017 Q3 | 653 Thousand CAD | -22.17% |
| 2016 Q2 | 833 Thousand CAD | -37.79% |
| 2016 Q3 | 785 Thousand CAD | -5.76% |
| 2016 Q4 | 790 Thousand CAD | 0.64% |
| 2016 FY | 790 Thousand CAD | -45.89% |
| 2016 Q1 | 1.33 Million CAD | -8.29% |
| 2015 Q3 | 1.58 Million CAD | 3.86% |
| 2015 FY | 1.46 Million CAD | 142.61% |
| 2015 Q4 | 1.46 Million CAD | -8.06% |
| 2015 Q2 | 1.52 Million CAD | 21.8% |
| 2015 Q1 | 1.25 Million CAD | 108.6% |
| 2014 Q4 | 601.78 Thousand CAD | 0.0% |
| 2014 Q2 | 1.00 CAD | 0.0% |
| 2014 Q3 | - CAD | -100.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | 601.78 Thousand CAD | 0.0% |
| 2013 Q3 | 202.61 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 50.726% |
| Avicanna Inc. | 4.54 Million CAD | -1920.889% |
| Avant Brands Inc. | 28.93 Million CAD | -217.358% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 32912.857% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | -1399.331% |
| MediPharm Labs Corp. | 9.89 Million CAD | -827.71% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | -13.441% |
| Canopy Growth Corporation | 77.29 Million CAD | -18.814% |
| Willow Biosciences Inc. | 221 Thousand CAD | -41453.846% |
| Auxly Cannabis Group Inc. | 31.42 Million CAD | -192.195% |